Johnson & Johnson: Expert Perspectives on the Treatment of DVT/PE and Reduction in the Risk of Recurrent DVT/PE, With a Focus on High-Risk Patient Populations

Sunday, September 29
11:30 am – 12:15 pm
Location: Exhibit Hall, Expert Theater 1

Speakers

Robert B. Takla, MD, Pamela Kushner, MD, FAAFP, James F. Neuenschwander MD, FACEP, FASAM

Theater Information

Distinguished presenters will provide expert perspectives on the treatment of deep vein thrombosis (DVT) and/or pulmonary embolism (PE) and reduction in the risk of recurrent DVT and/or PE. In addition, this discussion includes high-risk patient populations and how obesity, cancer, fragility, and renal impairment increase risks of recurrent DVT/PE.

Supported by Johnson & Johnson